Thailand · Delayed Price · Currency is THB Healthlead PCL Statistics
Total Valuation
Healthlead PCL has a market cap or net worth of THB 2.08 billion. The enterprise value is 1.88 billion.
| Market Cap | 2.08B |
| Enterprise Value | 1.88B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
Healthlead PCL has 266.48 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 266.48M |
| Shares Outstanding | 266.48M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 71.74% |
| Owned by Institutions (%) | 0.19% |
| Float | 75.30M |
Valuation Ratios
The trailing PE ratio is 24.86.
| PE Ratio | 24.86 |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | 25.06 |
| P/OCF Ratio | 15.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.51, with an EV/FCF ratio of 22.71.
| EV / Earnings | 22.10 |
| EV / Sales | 0.86 |
| EV / EBITDA | 9.51 |
| EV / EBIT | 16.59 |
| EV / FCF | 22.71 |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.64 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 3.65 |
| Interest Coverage | 7.27 |
Financial Efficiency
Return on equity (ROE) is 8.85% and return on invested capital (ROIC) is 5.70%.
| Return on Equity (ROE) | 8.85% |
| Return on Assets (ROA) | 4.86% |
| Return on Invested Capital (ROIC) | 5.70% |
| Return on Capital Employed (ROCE) | 9.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.50 |
| Inventory Turnover | 5.41 |
Taxes
In the past 12 months, Healthlead PCL has paid 19.57 million in taxes.
| Income Tax | 19.57M |
| Effective Tax Rate | 18.67% |
Stock Price Statistics
The stock price has decreased by -3.70% in the last 52 weeks. The beta is 0.25, so Healthlead PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -3.70% |
| 50-Day Moving Average | 7.23 |
| 200-Day Moving Average | 7.73 |
| Relative Strength Index (RSI) | 77.00 |
| Average Volume (20 Days) | 126,920 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healthlead PCL had revenue of THB 2.19 billion and earned 85.23 million in profits. Earnings per share was 0.31.
| Revenue | 2.19B |
| Gross Profit | 556.75M |
| Operating Income | 113.55M |
| Pretax Income | 104.80M |
| Net Income | 85.23M |
| EBITDA | 158.63M |
| EBIT | 113.55M |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 497.94 million in cash and 303.00 million in debt, giving a net cash position of 194.94 million or 0.73 per share.
| Cash & Cash Equivalents | 497.94M |
| Total Debt | 303.00M |
| Net Cash | 194.94M |
| Net Cash Per Share | 0.73 |
| Equity (Book Value) | 968.78M |
| Book Value Per Share | 3.62 |
| Working Capital | 618.94M |
Cash Flow
In the last 12 months, operating cash flow was 134.88 million and capital expenditures -51.92 million, giving a free cash flow of 82.95 million.
| Operating Cash Flow | 134.88M |
| Capital Expenditures | -51.92M |
| Free Cash Flow | 82.95M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 25.46%, with operating and profit margins of 5.19% and 3.90%.
| Gross Margin | 25.46% |
| Operating Margin | 5.19% |
| Pretax Margin | 4.79% |
| Profit Margin | 3.90% |
| EBITDA Margin | 7.25% |
| EBIT Margin | 5.19% |
| FCF Margin | 3.79% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 2.19%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 2.19% |
| Dividend Growth (YoY) | 13.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.25% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 2.31% |
| Earnings Yield | 4.10% |
| FCF Yield | 3.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healthlead PCL has an Altman Z-Score of 4.94 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.94 |
| Piotroski F-Score | 6 |